ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • Morning Stiffness
  • Morphea
  • morphea and histology
  • Morphea and pediatric rheumatology
  • morphea and scleroderma
  • morphea and systemic sclerosis
  • Mortality
  • mortality and osteoarthritis
  • mortality and population studies
  • Mortality and Rheumatoid arthritis
  • Motivational interviewing
  • motivational interviewing and outcomes
  • motivational interviewing and physical activity
  • Mouse
  • mouse and auto-immunity
  • Mouse model
  • mouse model and cd11c
  • mouse model and imaging techniques
  • mouse model and joint damage
  • mouse model and mitochondria
  • mouse model and myositis
  • mouse model and nephritis
  • mouse model and neuropsychiatric disorders
  • mouse model and neutrophils
  • mouse model and osteoarthritis
  • mouse model and osteoclasts
  • Mouse model and pain
  • mouse model and pediatric rheumatology
  • mouse model and phagocytosis
  • mouse model and pharmacology
  • mouse model and platelets
  • mouse model and psoriasis
  • mouse model and psoriatic arthritis
  • mouse model and reactive arthritis
  • mouse model and regulatory cells
  • mouse model and resolution of disease
  • mouse model and rheumatoid arthritis
  • mouse model and rheumatoid arthritis (RA)
  • mouse model and salivary hypofunction
  • mouse model and skin
  • mouse model and small molecules
  • mouse model and spondylarthritis
  • mouse model and spondylarthropathy
  • mouse model and stress
  • mouse model and synovial cells
  • mouse model and synovium
  • mouse model and systemic lupus erythematosus (SLE)
  • mouse model and systemic sclerosis
  • mouse model and therapeutic targeting
  • mouse model and tolerance
  • mouse model and toll-like receptors
  • mouse model and transcription factor
  • mouse model and treatment
  • mouse model and tuberculosis
  • mouse model and tumor necrosis factor (TNF)
  • mouse model and vasculitis
  • Mouse Models, Lupus
  • Mouse Models, Other
  • Mouse Models, RA
  • MPO
  • MRI
  • MRI and ankylosing spondylitis (AS)
  • MRI and axial spondyloarthritis
  • MRI and bone marrow edema
  • MRI and cardiovascular disease
  • MRI and chronic recurrent multifocal osteomyelitis (CRMO)
  • MRI and classification criteria
  • MRI and cytokines
  • MRI and diagnosis
  • MRI and diagnostic criteria
  • MRI and inflammation
  • MRI and inflammatory bowel disease (IBD)
  • MRI and injury
  • MRI and juvenile arthritis
  • MRI and juvenile dermatomyositis
  • MRI and low back pain
  • MRI and Mitochondrial transplantation
  • MRI and myositis
  • MRI and neurologic involvement
  • MRI and osteoarthritis
  • MRI and osteophytosis
  • MRI and osteoporosis
  • MRI and polymyalgia rheumatica
  • MRI and psoriatic arthritis
  • MRI and rheumatoid arthritis (RA)
  • MRI and shoulder disorders
  • MRI and spondylarthritis
  • MRI and synovitis
  • MRI and systemic lupus erythematosus (SLE)
  • MRI and takayasu arteritis
  • MRI and therapy
  • MRI and ultrasonography
  • MRI and ultrasound
  • MRI and Wegener's granulomatosis
  • MRI perfusion imaging
  • mrss
  • MSCs
  • MSCs and ev
  • MSCs and rheumatoid arthritis (RA)
  • msu
  • mTor
  • mTor and metabolism
  • mTor and monocytes
  • mTor and proteinuria
  • mTor and rheumatoid arthritis (RA)
  • mTor and signal transduction
  • mTor and systemic lupus erythematosus (SLE)
  • mTor and T cells
  • mTORC1
  • Muckle-Wells syndrome
  • Muckle-Wells syndrome and canakinumab
  • Muckle-Wells syndrome and genetic disorders
  • Muckle-Wells syndrome and inflammation
  • Muckle-Wells syndrome and interleukins (IL)
  • mucosal barriers
  • mucosal barriers and rheumatoid arthritis (RA)
  • mucosal T cells and mucosal barriers
  • mucosal T cells and rheumatoid arthritis (RA)
  • mucosal T cells and spondylarthritis
  • mucosal T cells and systemic lupus erythematosus (SLE)
  • multi-biomarker disease activity score
  • Multi-Cohort
  • Multi-disciplinary Consensus
  • Multicenter study
  • multicenter study and outcomes
  • multicenter study and pain
  • multicenter study and patient-reported outcome measures
  • multicenter study and primary care
  • multicenter study and rheumatoid arthritis (RA)
  • multicenter study and thrombosis
  • multicenter study and uveitis
  • Multicentric reticulohistiocytosis
  • Multidisciplinary
  • Multidisciplinary pain team
  • multidisciplinary pain team and rehabilitation
  • multidisciplinary unit
  • multimorbidity
  • multiorgan failure
  • Multiple cause analysis
  • multiple imputation
  • multiple imputation and systemic lupus erythematosus (SLE)
  • multiple imputation and tumor necrosis factor (TNF)
  • multiple sclerosis
  • muscarinic receptors
  • Muscle Biology
  • muscle biopsy
  • muscle biopsy and myositis
  • muscle biopsy and polymyositis
  • muscle biopsy and rheumatoid arthritis
  • muscle biopsy and rheumatoid arthritis (RA)
  • muscle biopsy and vasculitis
  • muscle enzyme
  • Muscle Function
  • muscle involvement
  • Muscle strength
  • muscle strength and Disease Activity
  • muscle strength and myopathy
  • muscle strength and myositis
  • muscle strength and osteoarthritis
  • muscle strength and pain
  • muscle strength and physical activity
  • muscle strength and physical function
  • muscle strength and rheumatoid arthritis (RA)
  • muscle strength and strength
  • Muscle Weakness
  • Musculoskeletal
  • Musculoskeletal and health care cost
  • Musculoskeletal and infection
  • Musculoskeletal and pain
  • Musculoskeletal and randomized trials
  • Musculoskeletal and sarcoidosis
  • Musculoskeletal and Work Disability
  • musculoskeletal curriculum
  • musculoskeletal curriculum and health education
  • musculoskeletal curriculum and intern
  • musculoskeletal curriculum and musculoskeletal sonography
  • musculoskeletal curriculum and physical examination
  • musculoskeletal curriculum and primary care
  • musculoskeletal curriculum and professional development
  • musculoskeletal curriculum and skill development
  • musculoskeletal curriculum and trainee
  • musculoskeletal curriculum and ultrasound
  • musculoskeletal disorders
  • musculoskeletal disorders and myositis
  • musculoskeletal disorders and non-pharmacologic intervention
  • musculoskeletal disorders and pain
  • musculoskeletal disorders and pain management
  • musculoskeletal disorders and pediatric rheumatology
  • musculoskeletal disorders and physical activity
  • musculoskeletal disorders and physical examination
  • musculoskeletal disorders and polyarthritis
  • musculoskeletal disorders and rheumatic disease
  • musculoskeletal disorders and sarcoidosis
  • Musculoskeletal disorders and sciatica
  • musculoskeletal disorders and tendonitis/bursitis
  • Musculoskeletal Examination
  • musculoskeletal sonography
  • musculoskeletal sonography and patient outcomes
  • Musculoskeletal sonography and pediatric rheumatology
  • musculoskeletal sonography and radiography
  • First |
  • « Previous Page
  • 36
  • 37
  • 38
  • 39
  • 40
  • [41]
  • 42
  • 43
  • 44
  • 45
  • 46
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology